Healthcare: Carl Icahn Takes Aim At Bristol-Myers Squibb

<p>Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.</p>